Biodesix
BDSX
47 hedge funds and large institutions have $67.6M invested in Biodesix in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 8 reducing their positions, and 6 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 8
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 46 → 47 (+1)
0.16% more ownership
Funds ownership: 0.79% → 0.95% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $85.6M → $67.6M (-$18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.5M |
| 2 |
CC
Cannell & Co
New York
|
+$3.23M |
| 3 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$1.76M |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$1.62M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.25M |
| 2 |
Millennium Management
New York
|
-$4.08M |
| 3 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$985K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$338K |
| 5 |
Squarepoint
New York
|
-$153K |
BDSX Hedge Fund Activity: Q2 2021 in Review
47 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2021, worth a combined $67.6M — down 21% from $85.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BDSX positions and 6 closed out — a net gain of 1 holder — while 28 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $6.5M. The largest seller was Putnam Investments, exiting entirely with an estimated $5.25M sold.
- 47 institutional investors held Biodesix (BDSX) as of Q2 2021, up from 46 in Q1 2021.
- Funds reported $67.6M of Biodesix stock for Q2 2021, down 21% quarter-over-quarter.
- 7 funds opened new Biodesix positions in Q2 2021 and 6 closed out, a net change of +1 holder.
- The largest Biodesix buyer in Q2 2021 was BlackRock, an estimated $6.5M added.
- The largest Biodesix seller in Q2 2021 was Putnam Investments, an estimated $5.25M sold.
Based on aggregated 13F filings for Q2 2021.